Clinical Trial Update: Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children [Phase 1]

View source ↗

Summary

Phase 1 pediatric trial update evaluating carfilzomib with cyclophosphamide and etoposide for relapsed or refractory solid tumors and leukemias; the study has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Solid Tumors

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Carfilzomib (Kyprolis) (carfilzomib)
• Etoposide (Etoposide)

Snippet

Sponsor: Stanford University | Conditions: Relapsed Solid Tumors, Refractory Solid Tumors | Phase 1 | Status: COMPLETED